Macrogenics Inc

Macrogenics Inc

MGNX

Get informed when a big investor buys or sells

+ Follow
Market Cap$234.55M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Macrogenics IncMacrogenics Inc-3.4--332%24.9
$6.00

Target Price by Analysts

53.8% upsideMacrogenics Target Price DetailsTarget Price
$-0.01

Current Fair Value

100.3% downside

Overvalued by 100.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$234.55 Million
Enterprise Value$272.53 Million
Dividend Yield$- (-)
Earnings per Share$-1.18
Beta1.18
Outstanding Shares63,449,780

Return

Return on Equity-331.91%ROE
Return on Assets-32.29%
Return on Invested Capital-53.58%

Valuation & Multiples

P/E Ratio-3.35P/E Ratio
PEG32.3PEG
Price to Sales1.95Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue1.73
Enterprise Value to EBIT-4.17
Enterprise Value to Net Income-4
Total Debt to Enterprise0.38
Debt to Equity4.93Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 14, 2026
EPS Estimate
$-0.57
Average shareholder expectation
Revenue Estimate
$15.24 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 11, 2026
EPS Estimate
$-0.41
Average shareholder expectation
Revenue Estimate
$30.56 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0782 7.47%
Total Calls180,200 108.81%
Total Puts14,100 6.82%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %68.35% 5.15%
Total Invested$124.75M 68.27%
Investors Holding113 24.00%

ESG Score

No data

About Macrogenics Inc

CEO: Scott Koenig